117 related articles for article (PubMed ID: 9206116)
1. Intrapancreatic cholecystokinin mediates vagally stimulated exocrine secretion from the rat pancreas.
He X; Nelson MT; Debas HT
Chin Med Sci J; 1996 Mar; 11(1):32-5. PubMed ID: 9206116
[TBL] [Abstract][Full Text] [Related]
2. Rat exocrine pancreatic secretion by vagal stimulation occurs via multiple mediators.
He X; Nelson MT; Debas HT
Chin Med Sci J; 1996 Jun; 11(2):73-7. PubMed ID: 9387412
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous cholecystokinin on vagally stimulated pancreatic secretion in dogs.
Kim CK; Lee KY; Wang T; Sun G; Chang TM; Chey WY
Am J Physiol; 1989 Dec; 257(6 Pt 1):G944-9. PubMed ID: 2481981
[TBL] [Abstract][Full Text] [Related]
4. Vagal stimulation of rat exocrine pancreatic secretion occurs via multiple mediators.
Nelson MT; Debas HT; Mulvihill SJ
Gastroenterology; 1993 Jul; 105(1):221-8. PubMed ID: 8099888
[TBL] [Abstract][Full Text] [Related]
5. Effects of intrapancreatic neuronal activation on cholecystokinin-induced exocrine secretion of isolated perfused rat pancreas.
Park HS; Park IS; Lee YL; Kwon HY; Park HJ
Pflugers Arch; 1999 Mar; 437(4):511-6. PubMed ID: 10089562
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
7. Endogenous cholecystokinin stimulates pancreatic enzyme secretion via vagal afferent pathway in rats.
Li Y; Owyang C
Gastroenterology; 1994 Aug; 107(2):525-31. PubMed ID: 8039628
[TBL] [Abstract][Full Text] [Related]
8. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
Nustede R; Schmidt WE; Lohmann C; Köhler H; Schlemminger R; Schafmayer A
Digestion; 1993; 54(2):79-83. PubMed ID: 8319843
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin suppresses food intake by a nonendocrine mechanism in rats.
Reidelberger RD; Varga G; Liehr RM; Castellanos DA; Rosenquist GL; Wong HC; Walsh JH
Am J Physiol; 1994 Oct; 267(4 Pt 2):R901-8. PubMed ID: 7524371
[TBL] [Abstract][Full Text] [Related]
10. Study on inhibition of pancreatic exocrine secretion by somatostatin in rats.
He X; Nelson MT; Debas H
Chin Med Sci J; 1996 Sep; 11(3):166-9. PubMed ID: 9387402
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of receptors for gastrin, cholecystokinin and GRP/bombesin in postprandial stimulation of exocrine pancreas in dogs.
Konturek SJ; Tasler J; Bilski J; Cieszkowski M; Cai RZ; Schally AV
J Physiol Pharmacol; 1993 Mar; 44(1):43-53. PubMed ID: 8390873
[TBL] [Abstract][Full Text] [Related]
12. Role of intraluminal nutrients in feedback regulation of pancreatic enzyme secretion.
Spannagel AW; Green GM
Ann N Y Acad Sci; 1994 Mar; 713():424-6. PubMed ID: 8185208
[No Abstract] [Full Text] [Related]
13. Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin.
Singer MV; Niebergall-Roth E
Cell Biol Int; 2009 Jan; 33(1):1-9. PubMed ID: 18948215
[TBL] [Abstract][Full Text] [Related]
14. Exocrine secretion of canine pancreas perfused extracorporeally.
Kowalewski K; Kolodej A; Kocylowski M
Eur Surg Res; 1978; 10(3):165-71. PubMed ID: 679962
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of cholecystokinin (CCK) receptor antagonists, MK-329 and L-365,260, for axonally-transported CCK binding sites on the rat vagus nerve.
Mercer JG; Lawrence CB
Neurosci Lett; 1992 Mar; 137(2):229-31. PubMed ID: 1374868
[TBL] [Abstract][Full Text] [Related]
16. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
17. Role of cholecystokinin in postprandial and vagally stimulated duodenal and gallbladder motility in dogs.
Thor P; Laskiewcz J; Maczka M; Konturek SJ
J Physiol Pharmacol; 1991 Dec; 42(4):381-8. PubMed ID: 1824297
[TBL] [Abstract][Full Text] [Related]
18. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats.
Yamamoto M; Wei L; Otani M; Harada M; Otsuki M
Regul Pept; 2012 Oct; 178(1-3):80-5. PubMed ID: 22796317
[TBL] [Abstract][Full Text] [Related]
19. Central and peripheral neural control of pancreatic exocrine secretion.
Niebergall-Roth E; Singer MV
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):523-38. PubMed ID: 11787756
[TBL] [Abstract][Full Text] [Related]
20. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
Anderson L; Dockray GJ
Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
